AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / PHARMACEUTICAL PREPARATIONS
Tonix Pharmaceuticals Holding Corp.
XNAS · usd
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001T49NZ9
5.17▲ 0.04 (0.78%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
Trailing P/E
—
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close
5.13
Day's Range
5.01 – 5.20
52-Week Range
5.01 – 20.58
Volume
750.6K
Avg Volume
839.6K
Share Statistics
Shares Outstanding
Employees
142
Exchange
XNAS
Listed
2009-02-13
Share count as of August 7, 2026

Tonix Pharmaceuticals Holding Corp. (TNXP) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Tonix Pharmaceuticals Holding Corp. (TNXP)
What is Tonix Pharmaceuticals Holding Corp.'s Market Cap?
Tonix Pharmaceuticals Holding Corp.'s Market Cap is $88.7M, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s Enterprise Value?
Tonix Pharmaceuticals Holding Corp.'s Enterprise Value is -$87.6M, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s Price / Sales?
Tonix Pharmaceuticals Holding Corp.'s Price / Sales is 3.0×, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s EV / Revenue?
Tonix Pharmaceuticals Holding Corp.'s EV / Revenue is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s EV / EBITDA?
Tonix Pharmaceuticals Holding Corp.'s EV / EBITDA is 0.5×, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s Revenue (TTM)?
Tonix Pharmaceuticals Holding Corp.'s Revenue (TTM) is $29.1M, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s Net Income (TTM)?
Tonix Pharmaceuticals Holding Corp.'s Net Income (TTM) is -$159.7M, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s EBITDA?
Tonix Pharmaceuticals Holding Corp.'s EBITDA is -$163.3M, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s Diluted EPS (TTM)?
Tonix Pharmaceuticals Holding Corp.'s Diluted EPS (TTM) is -9.31, based on as-reported figures from SEC (XBRL) filings.
What is Tonix Pharmaceuticals Holding Corp.'s EBITDA Margin?
Tonix Pharmaceuticals Holding Corp.'s EBITDA Margin is -561.1%, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · TNXPAs-filed SEC (XBRL) data
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands of USD, except per-share data)
Source: Akyla.ai
Line ItemJun 30, 2026Dec 31, 2025Sep 30, 2025Jun 30, 2025Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022
REVENUE:
Total product revenues——
YoY growth+457.6%——
COSTS AND EXPENSES:
Cost of Revenue
Research and Development Expense
Selling, General and Administrative Expense
Total operating expenses
% of revenue414.1%——
Operating loss
% of revenue-314.1%——
Grant income
Interest Expense
Non-Operating Income (Expense)
Net loss available to common stockholders
Earnings Per Share (Basic)
Earnings Per Share (Diluted)